Kidney International· 2018Q1
Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016
- 1,443citations
- Q1SCImago
- 2018year
Short summary
Chronic kidney disease (CKD) incidence and prevalence surged globally between 1990 and 2016, with incidence rising 89% and prevalence 87%. This increase is primarily driven by population growth and aging, but in some regions, diabetes and hypertension are significant contributing factors.
AI-generated from the title and abstract; the full text is not read.
Key points
- CKD incidence increased by 89% and prevalence by 87% globally from 1990-2016.
- Population growth and aging are the primary drivers of increased CKD burden.
- Diabetes and hypertension are accelerating CKD burden in certain regions.
- CKD burden is disproportionately higher in low and lower-middle-income countries (63%).
- An inverse relationship exists between age-standardized CKD DALY rates and healthcare access/quality.
AI-generated from the title and abstract; the full text is not read.
Abstract
The last quarter century witnessed significant population growth, aging, and major changes in epidemiologic trends, which may have shaped the state of chronic kidney disease (CKD) epidemiology. Here, we used the Global Burden of Disease study data and methodologies to describe the change in burden of CKD from 1990 to 2016 involving incidence, prevalence, death, and disability-adjusted-life-years (DALYs). Globally, the incidence of CKD increased by 89% to 21,328,972 (uncertainty interval 19,100,079- 23,599,380), prevalence increased by 87% to 275,929,799 (uncertainty interval 252,442,316-300,414,224), death due to CKD increased by 98% to 1,186,561 (uncertainty interval 1,150,743-1,236,564), and DALYs increased by 62% to 35,032,384 (uncertainty interval 32,622,073-37,954,350). Measures of burden varied substantially by level of development and geography. Decomposition analyses showed that the increase in CKD DALYs was driven by population growth and aging. Globally and in most Global Burden of Disease study regions, age-standardized DALY rates decreased, except in High-income North America, Central Latin America, Oceania, Southern Sub-Saharan Africa, and Central Asia, where the increased burden of CKD due to diabetes and to a lesser extent CKD due to hypertension and other causes outpaced burden expected by demographic expansion. More of the CKD burden (63%) was in low and lower-middle-income countries. There was an inverse relationship between age-standardized CKD DALY rate and health care access and quality of care. Frontier analyses showed significant opportunities for improvement at all levels of the development spectrum. Thus, the global toll of CKD is significant, rising, and unevenly distributed; it is primarily driven by demographic expansion and in some regions a significant tide of diabetes. Opportunities exist to reduce CKD burden at all levels of development.
The authors' abstract, as published at the source. Kidney International, 2018 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Nephrology
NephrologyMedicine